Search
for
Sort by
Research 61–90 of 237
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Utility of azathioprine, methotrexate and cyclosporine as steroid‐sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients
- Drug eruptions in dermatology
- Association of vitamin D level with alopecia areata
- Symptom management in inflammatory bowel disease
- Frequency and associated factors of hair loss among patients with inflammatory bowel disease
- Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review
- Disease severity scoring systems in dermatology
- Hair loss and its management in children
- Advances in Hair Diseases
- In silico analysis of ethyl acetate Bruguiera gymnorhiza leaf extracts as an anti-inflammatory agent
- Ottawa, Ontario, Canada, February 13–16, 2013
- Alopecia Areata in an Adolescent With Inflammatory Bowel Disease
- Ayurvedic approach for managing Indralupta (Alopecia Areata): A Case Study
- Increase in IL-15 levels in patients with alopecia areata
- Current and future pharmacotherapy for alopecia areata
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Acne and acneiform eruptions
- Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
- New therapies for alopecia areata
- Treatments for alopecia areata: a network meta-analysis
- Alopecia Areata and Alopecia Areata Incognita
- Alopecia Areata
- Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome
- Compounding as a Current Therapeutic Option in Dermatology
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control